Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 87747742 | 8774774 | 2 | F | 20160801 | 20120910 | 20160808 | EXP | US-PFIZER INC-2012220716 | PFIZER | 75.00 | YR | F | Y | 45.81000 | KG | 20160808 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 87747742 | 8774774 | 1 | PS | ARTHROTEC | DICLOFENAC SODIUMMISOPROSTOL | 1 | Oral | 150 MG, DAILY | C111508 | 20607 | 150 | MG | TABLET | QD | |||||
| 87747742 | 8774774 | 2 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 20 MG, DAILY | 20702 | 20 | MG | FILM-COATED TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 87747742 | 8774774 | 1 | Arthritis |
| 87747742 | 8774774 | 2 | Cardiac disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 87747742 | 8774774 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 87747742 | 8774774 | Arthritis | |
| 87747742 | 8774774 | Myocardial infarction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 87747742 | 8774774 | 2 | 1992 | 0 |